WebSep 6, 2024 · Systemic sclerosis (SSc) is a heterogenous, multisystem autoimmune disease defined by fibrosis and classified by extent of skin and organ involvement with varying clinical manifestations, progression rates, morbidity, and mortality. ... NK, natural killer; IRF5, interferon regulatory factor 5; PDC-E2, E2 component of pyruvate dehydrogenase ... WebFurther genetic studies have implicated CD226 and IRF5 (14, 15). Genetic studies in different populations have identified several human leukocyte antigens (HLAs) ... Initial promising results for tocilizumab in the treatment of systemic sclerosis were obtained from the phase 2 trial faSScinate (A Study of RoActemra/Actemra (Tocilizumab) ...
3663 - Gene ResultIRF5 interferon regulatory factor 5 [ (human)]
WebMay 1, 2010 · IRF5 INTERFERON HAPLOTYPE SYSTEMIC SCLEROSIS Systemic sclerosis (SSc) is an orphan complex multiorgan disease affecting the microvascular network, the immune system, and connective tissue. Progressive organ failure makes SSc a severe chronic disease leading to major disability or death 1. WebDescription Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs. Autoimmune disorders occur when the immune system malfunctions and … csharp string to stream
Systemic scleroderma: MedlinePlus Genetics
WebJan 23, 2013 · Systemic sclerosis (SSc) is a fibrotic autoimmune disease in which the genetic component plays an important role. One of the strongest SSc association signals … Webstudies have implicated CD226 and IRF5 (14, 15). Genetic studies in ... systemic sclerosis through a genome wide association strategy. J Transl Med. (2010) 8:O1. doi: 10.1186/1479-5876-8-S1-O1 16 ... WebSystemic sclerosis is a type of scleroderma, an autoimmune disease where your connective tissue grows too quickly. ... IRF5, STAT4, CD247, and others may predict who’s at higher … c sharp string to lowercase